Mai Capital Management Abbott Laboratories Transaction History

Mai Capital Management

$10.1 Billion
Q3 2024

A detailed history of Mai Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Mai Capital Management holds 401,386 shares of ABT stock, worth $45.9 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

401,386

Previous 411,290 2.41%

Holding current value

$45.9 Million

Previous $42.7 Million 7.08%

% of portfolio

0.45%

Previous 0.43%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$100.07 - $118.13 $991,093 - $1.17 Million	-9,904 Reduced 2.41%	401,386 $45.8 Million
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $197,833 - $220,832	1,964 Added 0.48%	411,290 $42.7 Million
Q1 2024 May 08, 2024	BUY	$109.52 - $120.96 $1.5 Million - $1.65 Million	13,671 Added 3.46%	409,326 $46.5 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $407,568 - $498,897	-4,519 Reduced 1.13%	395,655 $43.5 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $1.05 Million - $1.26 Million	10,979 Added 2.82%	400,174 $38.8 Million
Q2 2023 Aug 02, 2023	BUY	$100.78 - $112.29 $1.3 Million - $1.45 Million	12,928 Added 3.44%	389,195 $42.4 Million
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $61,990 - $72,966	640 Added 0.17%	376,267 $38.1 Million
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $13,213 - $15,501	-139 Reduced 0.04%	375,627 $41.2 Million
Q3 2022 Nov 15, 2022	BUY	$96.76 - $112.03 $1.4 Million - $1.62 Million	14,475 Added 4.01%	375,766 $36.4 Million
Q2 2022 Jul 19, 2022	BUY	$102.07 - $123.37 $1.44 Million - $1.74 Million	14,119 Added 4.07%	361,291 $39.3 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $1.68 Million - $2.05 Million	14,737 Added 4.43%	347,172 $41.1 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $809,172 - $990,785	7,004 Added 2.15%	332,435 $46.8 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $1.56 Million - $1.73 Million	13,415 Added 4.3%	325,431 $38.4 Million
Q2 2021 Jul 19, 2021	BUY	$105.79 - $124.53 $694,934 - $818,037	6,569 Added 2.15%	312,016 $36.2 Million
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $1.65 Million - $1.95 Million	15,169 Added 5.23%	305,447 $36.6 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $655,200 - $713,980	6,240 Added 2.2%	290,278 $31.8 Million
Q3 2020 Oct 26, 2020	BUY	$91.64 - $111.29 $129,578 - $157,364	1,414 Added 0.5%	284,038 $30.9 Million
Q2 2020 Jul 27, 2020	BUY	$76.57 - $98.0 $492,345 - $630,140	6,430 Added 2.33%	282,624 $25.8 Million
Q1 2020 Apr 16, 2020	SELL	$62.82 - $91.86 $177,654 - $259,780	-2,828 Reduced 1.01%	276,194 $21.8 Million
Q4 2019 Feb 03, 2020	BUY	$78.51 - $87.4 $2.88 Million - $3.21 Million	36,691 Added 15.14%	279,022 $24.2 Million
Q3 2019 Oct 29, 2019	SELL	$81.84 - $88.74 $767,986 - $832,736	-9,384 Reduced 3.73%	242,331 $20.3 Million
Q2 2019 Aug 15, 2019	SELL	$72.88 - $85.0 $812,539 - $947,665	-11,149 Reduced 4.24%	251,715 $21.2 Million
Q1 2019 Apr 29, 2019	SELL	$66.22 - $80.06 $118,600 - $143,387	-1,791 Reduced 0.68%	262,864 $21 Million
Q4 2018 Jan 30, 2019	BUY	$65.56 - $74.27 $340,190 - $385,387	5,189 Added 2.0%	264,655 $19.1 Million
Q3 2018 Oct 12, 2018	BUY	$60.81 - $73.36 $50,289 - $60,668	827 Added 0.32%	259,466 $19 Million
Q2 2018 Aug 16, 2018	BUY	$57.57 - $63.54 $68,162 - $75,231	1,184 Added 0.46%	258,639 $15.8 Million
Q1 2018 Apr 17, 2018	BUY	$56.27 - $63.62 $80,916 - $91,485	1,438 Added 0.56%	257,455 $15.4 Million
Q4 2017 Jan 30, 2018	SELL	$53.68 - $57.47 $275,700 - $295,165	-5,136 Reduced 1.97%	256,017 $14.6 Million
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $22,444 - $25,049	467 Added 0.18%	261,153 $13.9 Million
Q2 2017 Aug 07, 2017	BUY	N/A	260,686	260,686 $12.7 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Account

Mai Capital Management Abbott Laboratories Transaction History